CAU
ASTH icon

Caxton Associates (UK)’s Astrana Health ASTH Stock Holding History

Caxton Associates (UK)’s Portfolio ASTH Stock Details ASTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$453K Buy
+9,766
New +$351K 0.01% 552
2025
Q3 		– Sell
-21,458
Closed -$534K – 964
2025
Q2 		$534K Buy
+21,458
New +$604K 0.01% 412

Other funds holding ASTH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
3C
325 Capital New York $419M AUM 75.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Caxton Associates (UK)'s ASTH Position: Q2 2026 in Review

Caxton Associates (UK) opened a new position in Astrana Health (ASTH) in Q2 2026: 9,766 shares worth $453K. The stake represents 0.01% of the portfolio and ranks #552 among its holdings. This is a return to the name: Caxton Associates (UK) previously reported a position in ASTH as recently as Q2 2025.

Caxton Associates (UK) first reported a position in ASTH in Q2 2025 and has held it in 2 quarters since. The position peaked at $534K in Q2 2025. 210 funds tracked by Wall St. Rank hold ASTH as of Q2 2026.

  • Caxton Associates (UK) held 9,766 shares of Astrana Health worth $453K as of Q2 2026.
  • Astrana Health was a new Caxton Associates (UK) position in Q2 2026.
  • Astrana Health made up 0.01% of Caxton Associates (UK)'s portfolio in Q2 2026, its #552 holding.
  • Caxton Associates (UK) first reported a position in Astrana Health in Q2 2025 and has held it in 2 quarters since.
  • Caxton Associates (UK)'s Astrana Health position peaked at $534K in Q2 2025.
  • 210 funds tracked by Wall St. Rank held Astrana Health as of Q2 2026.

Based on Caxton Associates (UK)'s 13F filing for Q2 2026, filed 14 Aug 2026.